Taiho Oncology, Inc.
Nadeem Khan, MD has an extensive background in medical and pharmaceutical fields. Currently serving as the Medical Director - mCRC at Taiho Oncology, Inc., Nadeem previously held positions at Syneos Health, Ferring Pharmaceuticals, Pharmacena Labs, and CITYMD, where Nadeem gained experience in various medical specialties. With a Doctor of Medicine degree from American University of Antigua and a Bachelor's Degree in Biology/Biological Sciences from Stony Brook University, Nadeem Khan, MD is a seasoned professional in the healthcare industry.
This person is not in any offices
Taiho Oncology, Inc.
2 followers
The mission of Taiho Oncology, Inc. is to improve the lives of patients with cancer, their families and their caregivers. The company specializes in the development of orally administered anti-cancer agents and markets these medicines for a range of tumor types in the U.S. Taiho Oncology’s growing pipeline of selectively targeted anti-cancer agents is led by a world-class clinical development organization. Taiho Oncology is a subsidiary of Taiho Pharmaceutical Co., Ltd. which is part of Otsuka Holdings Co., Ltd. Taiho Oncology is headquartered in Princeton, New Jersey and oversees its parent company’s European and Canadian operations, which are located in Zug, Switzerland and Oakville, Ontario, Canada. For more information, visit www.taihooncology.com